Solagran is commercialising this group of therapeutic products, which are obtained using unique patented multi-stage extraction processes that employ very soft technology to extract 'live elements' of the conifer tree foliage without damaging their biological activity. These completely natural products have shown to have multifaceted therapeutic actions with high efficacy, and are remarkably free of side effects. Most are compositionally complex, containing variously chlorophyll, carotenoids, polyprenols, vitamins, diterpene resin acid derivatives, bioflavonoids, minerals and other components. Bioeffectives® have been used to improve health in times of great historical significance. The bioactive green needle extract we now know as (CCCP), later developed into CGNC (Bioeffective® A), was used on a wide scale in 1940's (during WWII) as a topical anti-infective and wound healer. During the 900-day siege of Leningrad (St Petersburg) it was also rationed to the city's population as part of a meagre daily food intake. Known as the "elixir of life", it helped save thousands from scurvy and starvation. More recently, Bioeffectives® were used to help workers involved in rescue and decontamination activities following the Chernobyl disaster. Following the transfer and acquisition of this unique Russian technology to Solagran in the 1990's, research, pre-clinical and clinical trials have continued and the Bioeffectives® family has grown. There are currently three TGA listed products commercialised in Australia. In addition, a number of products are available in Russia including Bioeffective R® , (Ropren®) a registered prescription pharmaceutical hepatoprotector used in the treatment of liver disease. Further, several Bioeffective A products have been approved and marketed in Malaysia and the UAE. There are currently 17 Bioeffectives® in the portfolio and research is on going into their incredible properties.
View Top Employees from SolagranWebsite | http://solagran.com |
Revenue | $7 million |
Employees | 12 (2 on RocketReach) |
Address | 98 106 Moray St, South Melbourne, Victoria 3205, AU |
Phone | +61 3 9820 2699 |
Fax | +61 3 9820 3155 |
Technologies |
JavaScript,
PHP,
G Suite
+13 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
Competitors | Active Biotech AB, Cilian AG, CuriRx, Inc, NOXXON Pharma AG, Nutra-Park Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Solagran employee's phone or email?
The Solagran annual revenue was $7 million in 2023.
2 people are employed at Solagran.
Solagran is based in South Melbourne, Victoria.
The NAICS codes for Solagran are [325, 32541, 3254, 32].
The SIC codes for Solagran are [28, 283].